Τόμος 28 (2010) – Τεύχος 2 – Άρθρο 4 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Ελληνική Έκδοση – Volume 28 (2010) – Issue 2 – Article 4 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-Greek Edition

Ξανθή Αποστολίδου, Τζωρτζ Δαδούς

Β΄ Καρδιολογική Κλινική, Αριστοτέλειο Πανεπιστήμιο, Θεσσαλονίκη, Ελλάς

Xanthi Apostolidou¹, George Dadous²

¹Cardiologist, ²Cardiologist Lecturer of Cardiology, Hippokration General Hospital, 2nd Department of Cardiology, Aristotle University, Thessaloniki, Hellas

2. Gouley B.A., McMillan T.M., Bellet S.: Ιdiopathic myocardial degeneration associated with pregnancy and especially the puerperium. Am. J. Med. Sci. 19: 185-199 (1937)

3. Pearson G.D., Veille J.C., Rahimtoola S., et al.: Peripartum cardiomyopathy. National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) Workshop recommendations and review. JAMA 283: 1183-1188 (2000)

4. Desai D., Moodley J., Naidoo D.: Peripartum cardiomyopathy: Experiences at King Edward VIII Hospital, Durban, South Africa and a review of the literature. Trop. Doct 25: 118-123 (1995)

5. Fett J.D., Christie L.G., Carraway R.D., Murphy J.G.: Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution. Mayo Proceed. 80: 1602-1606 (2005)

6. Davidson N.M., Parry E.H.: Peripartum cardiac failure. Q. J. Med. 47:431-461 (1978)

7. Demakis J.G., Rahimtoola S.H., Sutton G.C., et al.: Natural course of peripartum cardiomyopathy. Circulation 44: 1053-1061 (1971)

8. Podewski E., Hilfiker A., Hilfi KerKleiner D., Kaminski K., Drexler H.: Stat 3 protects female hearts from postpartum cardiomyopathy in the mouse: the potential role of prolactin. European Society of Cardiology Meeting, Munich, 2004 (Abstract 2178)

9. Kuhl U., Pauschinger M., Seeberg B., et al.: Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation 112: 1965-1970 (2005)

10. Sliwa K., Skudicky D., Bergemann A., Candy G., Puren A., Sareli P.: Peripartum cardiomyopathy: analysis of clinical outcome, left ventricular function, plasma levels of cytokines and Fas/Apo-1. J. Am. Coll. Cardiol. 35: 701-705 (2000)

11. Ansari A.A., Fett J.D., Carraway R.D., Mayne A.E., Onlamoon M., Sundstrom J.B.: Autoimmune mechanisms as the basis for human peripartum cardiomyopathy. Clin. Rev. Allergy Immunol. 23: 289-312 (2002)

12. Fett J.D., Sundstrom J.B., Ansari A.A., Combs G.F.,Jr: Peripartum cardiomyopathy: a selenium disconnection and an autoimmune connection. Int. J. Cardiol. 86: 311-315 (2002)

13. Hayakawa Y., Chandra M., Wenfeng M., et al.: Inhibition of cardiac myocyte apoptosis improves cardiac function and abolishes mortality in peripartum cardiomyopathy of Gα(q) transgenic mice. Circulation 108: 1037-1042 (2003)

14. Hilfiker-Kleiner D., Kaminski K., Podewski E., et al.: A cathepsin D-cleaved 16-kDa form of prolactin mediates postpartum cardiomyopathy. Cell 128: 589-600 (2007)

15. Hilfiker-Kleiner D., Meyer G.P., Schieffer E., et al.: Recovery from postpartum cardiomyopathy in 2 patients by blocking prolactin release with bromocriptine. J. Am. Coll. Cardiol. 50: 2354–2355 (2007)

16. Sliwa K., Fett J., Elkayam U.: Peripartum cardiomyopathy, Seminar. Lancet 368: 687-693 (2006)

17. Kass Wenger N., Collins P.: In: (Oakley C., ed) Women & Heart Disease. 2nd Ed., Ch. 25, Pp. 341-373, Taylor & Francis, 2005

18. Gleicher N.: Graft-versus host disease and immunologic rejection: implications for diagnosis and treatments of pregnancy complications. Expert Rev. Obstet. Gynecol. 3: 37-49 (2008)

19. Gleicher N., Elkayam U.: Peripartum cardiomyopathy, an autoimmune manifestation of allograft rejection? Autoimmun. Rev., (2008), doi:10.1016/j.autrev.2008.12.003

20. Hilfiker-Kleiner D., Sliwa K., Drexler H.:. Peripartum Cardiomyopathy: Recent Insights in its Pathophysiology Trends Cardiovasc. Med. 18: 173-179 (2008)

21. Vera-Lastra O., Jara L.J., Espinoza L.R.: Prolactin and autoimmunity. Autoimmune Rev. 1: 360-364 (2002)

22. Orbacj H., Shoenfeld Y.: Hyperprolactinemia and autoimmune diseases. Autoimmune Rev. 6: 537-542 (2007)

23. Oakley C., Warnes C.A.: In: (Oakley C., ed.) Heart Disease in Pregnancy, 2nd Ed, Ch. 14, pp. 186-197, Blackwell Publishing, 2007

24. Fennira S., Demiraj A., Khouaja A., Boujnah M.-R.: La cardiomyopathie du péripartum – Peripartum cardiomyopathy Annales de Cardiologie et d’Angéiologie 55: 271-275 (2006)

25. Withlin A.G., Mabie W.C., Sibai B.M.: Peripartum cardiomyopathy: a longitudinal echocardiographic study. Am. J. Obstet. Gynecol. 177: 1129-1132 (1997)

26. Lampert M.B., Weinert L., Hibbard J., Korcarz C., Lindheimer M., Lang R.M.: Contractile reserve in patients with peripartum cardiomyopathy and recovered left ventricular function dysfunction. Am. J. Obstet. Gynecol. 176: 189-195 (1997)

27. Elkayam U., Padmini P., Tummala P., et al.: Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy. N. Engl. J. Med. 344: 1567-1571 (2001)